The prescribing of neuroleptic drugs for people with learning disabilities living in Leicestershire.
In the mid-90s, one in four Leicestershire adults with learning disabilities took neuroleptics, with NHS homes prescribing far more than community homes.
01Research in Context
What this study did
Doctors looked at every adult with learning disabilities living in Leicestershire. They counted how many were taking neuroleptic pills. They split the group by where the people lived: NHS homes or community homes.
The team wrote down dose size and linked it to staff notes about behavior problems.
What they found
Twenty-three out of every 100 residents were on neuroleptics. NHS homes handed out the drugs three times more often than community homes. Higher doses matched higher behavior scores in the notes.
How this fits with other research
Rose et al. (2000) asked the same question across the whole UK five years later. They found the same pattern: challenging behavior, not mental illness, drives the prescriptions.
de Kuijper et al. (2010) repeated the count in the Netherlands and saw nearly the same rate: 32%. Again, behavior was the main reason written on the scripts.
Hsu et al. (2014) tracked Taiwanese outpatients for ten years. Psychotropic use climbed from 18% to 23%, showing the trend did not flatten after 1995.
Why it matters
If you work in a residential home, check who is on antipsychotics and why. Behavior plans, not pills, should come first. Start one review this week: pick the highest-dose chart and ask if a functional assessment has been done lately.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Schedule one medication-review meeting for your highest-dose resident and bring recent behavior data.
02At a glance
03Original abstract
Neuroleptics are prescribed for 23% of individuals with learning disabilities resident in Leicestershire, England. The rate of neuroleptic prescription is significantly higher in individuals resident in N.H.S. facilities (44%) than in non-N.H.S. managed community facilities (13%). Significantly higher doses of neuroleptics are prescribed to individuals resident in N.H.S. facilities. However, ratings for the level of behavioural disturbance were significantly higher in N.H.S. facilities. The decision to prescribe neuroleptics was associated with disturbed behaviour, and higher doses of neuroleptic medication prescribed were associated with more disturbed behaviour.
Journal of intellectual disability research : JIDR, 1995 · doi:10.1111/j.1365-2788.1995.tb00569.x